Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic Alzheimer disease
Maartje I. Kester, Charlotte E. Teunissen, Daniel L. Crimmins, Elizabeth M. Herries, Jac K.H. Ladenson, Philip Scheltens, Wiesje M. Van Der Flier, John C. Morris, David M. Holtzman, Anne M. Fagan
Dive into the research topics of 'Neurogranin as a cerebrospinal fluid biomarker for synaptic loss in symptomatic Alzheimer disease'. Together they form a unique fingerprint.